Drug-induced chromatin accessibility changes associate with sensitivity to liver tumor promotion

This work explores quantitative chromatin accessibility, transcriptional and cis-acting gene regulatory variations underlying mouse strain–specific differences in drug-induced liver tumor promotion sensitivity.